Progress in PBC: Gideon Hirschfield, MD
from Gastroenterology Learning Network Hosted by Gastroenterology Learning Network
Dr Gideon Hirschfield from the University of Toronto Centre for Liver Disease discusses the potential of new drugs, including selective PPAR agents such as seladelpar, for the treatment of primary biliary cholangitis.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of Gastroenterology Learning Network?
This episode is 17 minutes long.
When was this Gastroenterology Learning Network episode published?
This episode was published on July 17, 2023.
Can I download this Gastroenterology Learning Network episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.